Scribd
Upload
45 views24 pages

Sun Pharma

This document provides an overview of Sun Pharma, the world's 5th largest pharmaceutical company, and discusses key drivers of global pharmaceutical demand and spending. It notes that global pharmaceutical spending is expected to grow to $1400-1430 billion by 2020, driven primarily by improved access and treatment in emerging markets, aging populations, and the treatment of chronic diseases. Developed markets will continue to account for over 60% of global spending, led by the United States.

Uploaded by

Suman Sourav
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
45 views24 pages

Sun Pharma

This document provides an overview of Sun Pharma, the world's 5th largest pharmaceutical company, and discusses key drivers of global pharmaceutical demand and spending. It notes that global pharmaceutical spending is expected to grow to $1400-1430 billion by 2020, driven primarily by improved access and treatment in emerging markets, aging populations, and the treatment of chronic diseases. Developed markets will continue to account for over 60% of global spending, led by the United States.

Uploaded by

Suman Sourav
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
You are on page 1/ 24

SUN

PHARMA

GROUP 3J
Suman Sourav
Kunal Joshi
Shivangi Maheshwari Vinay Gundecha
Ekshan Kumar

Sun Pharma at glance

Worlds 5TH largest pharma


company

Sun Pharma Today

Global Manufacturing Footprint

Ranking in doctor category

Track record of growth

Sun Pharma Timeline

FACTORS
AFFECTING
AGGREGATE
SUPPLY

Best in class field force productivity

GDP Data: India, World and US

Turning around acquisitions

Key Deals

Research and Development


Investment

ANDP Approvals

Sustained Profitability Vs Peers

Developed market patent expiry exposure

FACTORS
AFFECTING
AGGREGATE
DEMAND

Global Growth Drivers


The key contributors of the US$ 349 billion in growth over the next five years will be:
1. Improving access to modern medicines in pharmerging countries;
2. Enhanced use of more expensive branded medicines in developed markets; and
3. Use of cheaper alternatives when loss of exclusivity happens
Global demand for pharmaceuticals will be driven by:
. Demographic trends
. Rise in diagnosis and treatment of chronic conditions
. Ageing and growing global population
. Improved access to healthcare
. Increasing per capita income

Global Pharma Spending


Region Wise Spending
Regions
Developed Markets
Pharmerging Markets
Other Markets
Global Pharmaceutical
Market

2015
684
249
135

2011-2015 CAGR
4.80%
11.90%
5.20%

2020
870-900
345-375
150-180

US $
billion
2016-2020
CAGR
3-6%
7-10%
1-4%

1069

6.20%

1400-1430

4-7%

63%
Contribution of developed markets to global pharmaceutical spending
Spending and Growth to 2020
The developed markets will contribute 63% of the spending, driven by the US. Original brands will represent 52%
of spending and 85% of global spending will be for medicines to treat non-communicable diseases. These
distributions of costs belie the very different perspective on a volume basis where lower-cost/higher-volume
medicines dominate the overall use of medicines.

Global Spending Forecast

Demand Drivers

Driving long term growth

Thank You.

You might also like